PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• MARKET ECOSYSTEM
• MARKET CHARACTERISTICS
• MARKET SEGMENTATION ANALYSIS
PART 05: MARKET SIZING
• MARKET DEFINITION
• MARKET SIZING 2017
• MARKET SIZE AND FORECAST 2017-2022
PART 06: FIVE FORCES ANALYSIS
• BARGAINING POWER OF BUYERS
• BARGAINING POWER OF SUPPLIERS
• THREAT OF NEW ENTRANTS
• THREAT OF SUBSTITUTES
• THREAT OF RIVALRY
• MARKET CONDITION
PART 07: PIPELINE LANDSCAPE
• DRUGS UNDER DEVELOPMENT
PART 08: MARKET SEGMENTATION BY PRODUCT TYPE
• SEGMENTATION BY PRODUCT TYPE
• COMPARISON BY PRODUCT
• OTC – MARKET SIZE AND FORECAST 2017-2022
• RX – MARKET SIZE AND FORECAST 2017-2022
• MARKET OPPORTUNITY BY PRODUCT
PART 09: CUSTOMER LANDSCAPE
PART 10:REGIONAL LANDSCAPE
• GEOGRAPHICAL SEGMENTATION
• REGIONAL COMPARISON
• AMERICAS – MARKET SIZE AND FORECAST 2017-2022
• EMEA – MARKET SIZE AND FORECAST 2017-2022
• APAC – MARKET SIZE AND FORECAST 2017-2022
• MARKET OPPORTUNITY
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• MARKET DRIVERS
• MARKET CHALLENGES
PART 13: MARKET TRENDS
• GROWING E-COMMERCE MARKET
• STRATEGIC ALLIANCES
• GROWING DISPOSABLE INCOME IS LEADING TO HIGHER HEALTHCARE EXPENDITURE
PART 14: VENDOR LANDSCAPE
• OVERVIEW
• LANDSCAPE DISRUPTION
PART 15: VENDOR ANALYSIS
• VENDORS COVERED
• VENDOR CLASSIFICATION
• MARKET POSITIONING OF VENDORS
• MERCK
• PFIZER
• SANOFI
• STRIDES ARCOLAB
• SUN PHARMACEUTICAL INDUSTRIES
PART 16: APPENDIX
• LIST OF ABBREVIATIONS
PART 17: EXPLORE TECHNAVIO
EXHIBIT 01: PARENT MARKET
EXHIBIT 02: GLOBAL VITAMIN MARKET
EXHIBIT 03: MARKET CHARACTERISTICS
EXHIBIT 04: MARKET SEGMENTS
EXHIBIT 05: MARKET DEFINITION: INCLUSIONS AND EXCLUSIONS CHECKLIST
EXHIBIT 06: MARKET SIZE 2017
EXHIBIT 07: VALIDATION TECHNIQUES EMPLOYED FOR MARKET SIZING 2017
EXHIBIT 08: GLOBAL VITAMIN D MARKET – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 09: GLOBAL VITAMIN D MARKET – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 10: FIVE FORCES ANALYSIS 2017
EXHIBIT 11: FIVE FORCES ANALYSIS 2022
EXHIBIT 12: BARGAINING POWER OF BUYERS
EXHIBIT 13: BARGAINING POWER OF SUPPLIERS
EXHIBIT 14: THREAT OF NEW ENTRANTS
EXHIBIT 15: THREAT OF SUBSTITUTES
EXHIBIT 16: THREAT OF RIVALRY
EXHIBIT 17: MARKET CONDITION – FIVE FORCES 2017
EXHIBIT 18: PIPELINE LANDSCAPE BY DEVELOPMENT PHASE
EXHIBIT 19: GLOBAL VITAMIN D PIPELINE: OVERVIEW
EXHIBIT 20: PRODUCT TYPE – MARKET SHARE 2017-2022 (%)
EXHIBIT 21: COMPARISON BY PRODUCT
EXHIBIT 22: OTC – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 23: OTC – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 24: RX – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 25: RX – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 26: MARKET OPPORTUNITY BY PRODUCT
EXHIBIT 27: CUSTOMER LANDSCAPE
EXHIBIT 28: GLOBAL – MARKET SHARE BY GEOGRAPHY 2017-2022 (%)
EXHIBIT 29: REGIONAL COMPARISON
EXHIBIT 30: AMERICAS – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 31: AMERICAS – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 32: TOP 3 COUNTRIES IN AMERICAS
EXHIBIT 33: EMEA – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 34: EMEA – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 35: TOP 3 COUNTRIES IN EMEA
EXHIBIT 36: APAC – MARKET SIZE AND FORECAST 2017-2022 ($ MN)
EXHIBIT 37: APAC – YEAR-OVER-YEAR GROWTH 2018-2022 (%)
EXHIBIT 38: TOP 3 COUNTRIES IN APAC
EXHIBIT 39: MARKET OPPORTUNITY
EXHIBIT 40: PERCENTAGE OF POPULATION AGED 60 YEARS AND ABOVE BY REGION (2015-2050)
EXHIBIT 41: VENDOR LANDSCAPE
EXHIBIT 42: LANDSCAPE DISRUPTION
EXHIBIT 43: VENDORS COVERED
EXHIBIT 44: VENDOR CLASSIFICATION
EXHIBIT 45: MARKET POSITIONING OF VENDORS
EXHIBIT 46: MERCK – OVERVIEW
EXHIBIT 47: MERCK – BUSINESS SEGMENTS
EXHIBIT 48: MERCK – ORGANIZATIONAL DEVELOPMENTS
EXHIBIT 49: MERCK – GEOGRAPHIC FOCUS
EXHIBIT 50: MERCK – SEGMENT FOCUS
EXHIBIT 51: MERCK – KEY OFFERINGS
EXHIBIT 52: MERCK – KEY CUSTOMERS
EXHIBIT 53: PFIZER – OVERVIEW
EXHIBIT 54: PFIZER – BUSINESS SEGMENTS
EXHIBIT 55: PFIZER – ORGANIZATIONAL DEVELOPMENTS
EXHIBIT 56: PFIZER – GEOGRAPHIC FOCUS
EXHIBIT 57: PFIZER – SEGMENT FOCUS
EXHIBIT 58: PFIZER – KEY OFFERINGS
EXHIBIT 59: PFIZER – KEY CUSTOMERS
EXHIBIT 60: SANOFI – OVERVIEW
EXHIBIT 61: SANOFI – BUSINESS SEGMENTS
EXHIBIT 62: SANOFI – ORGANIZATIONAL DEVELOPMENTS
EXHIBIT 63: SANOFI – GEOGRAPHIC FOCUS
EXHIBIT 64: SANOFI – SEGMENT FOCUS
EXHIBIT 65: SANOFI – KEY OFFERINGS
EXHIBIT 66: SANOFI – KEY CUSTOMERS
EXHIBIT 67: STRIDES ARCOLAB – OVERVIEW
EXHIBIT 68: STRIDES ARCOLAB – BUSINESS SEGMENTS
EXHIBIT 69: STRIDES ARCOLAB – ORGANIZATIONAL DEVELOPMENTS
EXHIBIT 70: STRIDES ARCOLAB – GEOGRAPHIC FOCUS
EXHIBIT 71: STRIDES ARCOLAB – SEGMENT FOCUS
EXHIBIT 72: STRIDES ARCOLAB – KEY OFFERINGS
EXHIBIT 73: STRIDES ARCOLAB – KEY CUSTOMERS
EXHIBIT 74: SUN PHARMACEUTICAL INDUSTRIES – OVERVIEW
EXHIBIT 75: SUN PHARMACEUTICAL INDUSTRIES – BUSINESS SEGMENTS
EXHIBIT 76: SUN PHARMACEUTICAL INDUSTRIES – ORGANIZATIONAL DEVELOPMENTS
EXHIBIT 77: SUN PHARMACEUTICAL INDUSTRIES – GEOGRAPHIC FOCUS
EXHIBIT 78: SUN PHARMACEUTICAL INDUSTRIES – SEGMENT FOCUS
EXHIBIT 79: SUN PHARMACEUTICAL INDUSTRIES – KEY OFFERINGS
EXHIBIT 80: SUN PHARMACEUTICAL INDUSTRIES – KEY CUSTOMERS
【掲載企業】
Merck、Pfizer、Sanofi、Strides Arcolab、and Sun Pharmaceutical Industries、
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。